Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-13T03:23:10.670Z Has data issue: false hasContentIssue false

Simultaneous Localization and Quantitation of Progesterone Receptor Immunoreactivity in Human Breast Carcinomas.

Published online by Cambridge University Press:  02 July 2020

K.A. Roth*
Affiliation:
Departments of Pathology and Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO, 63110
Get access

Extract

The presence of estrogen and progesterone receptors on human breast carcinomas correlates with both response to hormonal therapy and survival. Quantitation of receptor activity is typically performed by radioreceptor assay on fresh frozen tumor tissue obtained at the time of surgical resection. Estrogen and progesterone receptor reactivity can also be detected immunohistochemically on frozen sections of breast cancer and in appropriately fixed paraffin embedded tissues. Several studies have shown that semi-quantitative visual determination and quantitative image analysis assessment of estrogen and progesterone receptor immunoreactivity on fixed tissue sections is highly correlated with biochemical measurements of receptor in frozen samples. We recently developed a procedure for the simultaneous localization and quantitation of antigens in fixed tissue samples that does not involve antigen extraction, radioactive materials, or image analysis. In this procedure, which we term a “Midwestern assay”, fixed tissue sections are used with antigen-specific enzyme-linked antibodies to generate soluble reaction products which are spectrophotometrically quantitatable, as in an ELISA, and deposited reaction products which are microscopically localizable, as in enzyme-based immunohistochemistry.

Type
Neoplasia: Abnormal Cell Growth or Death/Apoptosis? Insights from Microscopy
Copyright
Copyright © Microscopy Society of America 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Clark, G.M.et al., The New England J. of Medicine 309(1983)1343.10.1056/NEJM198312013092240CrossRefGoogle Scholar
2.Fritz, P.et al., Pathologica 87(1995)300.Google Scholar
3.Gin, D.D.et al., J Clin Path 41(1988)444.Google Scholar
4.Scheres, H.M.E.J Clin Path 41(1988)623.10.1136/jcp.41.6.623CrossRefGoogle Scholar
5.Roth, K.A.et al. submitted.Google Scholar
6. This work was supported by funds from the Washington University School of Medicine, Department of Pathology. I acknowledge the expert assistance received from the Washington University School of Medicine, Department of Molecular Biology and Pharmacology Histology facility.Google Scholar